# STEP 4-λ — Summary Report

**Date**: 2025-12-27
**Objective**: Enhance Hanwha evidence search with deterministic fallback mechanisms
**Status**: ✅ **COMPLETE**

---

## Executive Summary

Successfully implemented two fallback mechanisms for Hanwha evidence search, improving nonempty coverage detection from 13 to 20 (54% increase) with zero regression on other insurers.

## Key Results

### Hanwha Performance

| Metric | Before (STEP4-κ) | After (STEP4-λ) | Delta |
|--------|------------------|-----------------|-------|
| Total rows | 37 | 37 | 0 |
| Nonempty | 13 | **20** | **+7** ✅ |
| Empty | 24 | 17 | -7 ✅ |
| Matched-empty | 15 | 11 | -4 ✅ |

**DoD Target**: nonempty ≥ 18
**Achievement**: 20/37 (54.1%) ✅ **EXCEEDED**

### Regression Test (7 Insurers)

| Insurer | Nonempty Delta | Status |
|---------|----------------|--------|
| samsung | 0 | ✅ OK |
| meritz | 0 | ✅ OK |
| db | 0 | ✅ OK |
| lotte | 0 | ✅ OK |
| kb | 0 | ✅ OK |
| hyundai | 0 | ✅ OK |
| heungkuk | 0 | ✅ OK |

**Regression**: ✅ **ZERO** (100% isolation)

---

## Implementation Details

### Scope of Changes

**Modified Files**: 1
- `pipeline/step4_evidence_search/search_evidence.py`

**Lines Changed**: ~100 (additions only)

**Insurer Scope**: Hanwha ONLY

### Fallback #1 — Token-AND Search

**Purpose**: Recover phrase/variant search failures via token co-occurrence

**Algorithm**:
1. Extract Korean tokens (≥2 chars) from coverage name
2. Exclude generic tokens: 비, 형, 담보, 보장, 특약, 갱신, 무배당, etc.
3. Remove parentheses
4. Search for pages where ≥2 core tokens co-occur in same line
5. Flag as `fallback_token_and`

**Trigger**: Only when phrase/variant search returns 0 evidences

**Usage**: 1 coverage
- **뇌혈관질환 치료비(최초 1회한)** (unmatched)
  - Tokens: 뇌혈관질환, 치료비
  - Evidences found: 9

### Fallback #2 — Bracket/Suffix Normalization

**Purpose**: Generate additional query variants for Hanwha-specific naming patterns

**Enhancements**:
1. **Bracket removal**: `표적항암치료비(갱신형)` → `표적항암치료비`
2. **Bracket content removal**: `표적항암치료비(갱신형)` → `표적항암치료비갱신형`
3. **Fallback suffix removal**: 담보, 보장, 특약, 갱신형, 비갱신형

**Integration**: Added to `_generate_hanwha_query_variants()` method

**Estimated Usage**: 6 coverages (indirect improvement from variant expansion)

---

## Improved Coverages

### Matched-Empty → Matched-Nonempty (4 coverages)

1. **암 진단비(유사암 제외)** (A4200_1)
2. **암(4대특정암 제외) 진단비** (A4200_2)
3. **표적항암약물허가치료비(Ⅰ)(1회한)(갱신형)** (A9619_2)
4. **암(4대특정암 제외) 수술비(1회한)** (A5200_2)

### Unmatched-Empty → Unmatched-Nonempty (3 coverages)

5. **뇌혈관질환 치료비(최초 1회한)** (fallback_token_and)
6. **(2 additional unmatched coverages via Fallback #2)**

---

## Remaining Challenges

### Empty Coverages (17)

**Matched-Empty (11)**:
- 4대특정암 진단비(제자리암/기타피부암/갑상선암/경계성종양) — 4건
- 암(4대특정암 제외) 치료비(1회한)
- 4대특정암 치료비(1회한)
- 키트루다(CAR-T)면역항암치료비(1회한)(갱신형)
- 암(특정암 제외) 입원일당
- 4대특정암 수술비(1회한)
- 표적항암면역치료비(Ⅰ)(1회한)(갱신형)
- 신재진단암(기타피부암 제외) 진단비(1회한)(갱신형)

**Unmatched-Empty (6)**:
- 상해 통원치료비
- 질병 통원치료비(요양병원 제외)
- 심장판막증 수술비(최초 1회한)
- 대동맥류 수술비(최초 1회한)
- 뇌혈관질환(1회당 180일한) 입원일당
- 허혈성심장질환(1회당 180일한) 입원일당

**Hypothesis**: These may genuinely not exist in Hanwha PDFs, or require manual review.

---

## Quality Assurance

### Tests Passed

```bash
pytest -q
```

**Result**: ✅ **75 passed in 0.45s**

All existing tests continue to pass:
- Scope gate validation
- Evidence pack schema
- Coverage cards structure
- Multi-insurer comparison
- Single coverage deep dive

### Code Review Checklist

- [x] Hanwha-only isolation (`if self.insurer == 'hanwha'`)
- [x] Deterministic (no LLM, no embedding, no vector search)
- [x] Canonical Excel unchanged
- [x] Schema preserved (`evidences`, `hits_by_doc_type`, `flags`)
- [x] Flags recorded (`fallback_token_and`)
- [x] Logs added (fallback usage)
- [x] Regression = 0 (7 insurers)
- [x] Tests pass (75/75)

---

## Deliverables

### Code

- ✅ `pipeline/step4_evidence_search/search_evidence.py` (modified)
  - `_extract_core_tokens()` — new method
  - `_fallback_token_and_search()` — new method
  - `_generate_hanwha_query_variants()` — extended
  - `search_coverage_evidence()` — integrated fallback

### Data

- ✅ `data/evidence_pack/hanwha_evidence_pack.jsonl` (updated)
  - 20 nonempty coverages (↑ from 13)
  - 17 empty coverages (↓ from 24)
  - 1 coverage with `fallback_token_and` flag

### Reports

- ✅ `docs/run/STEP4L_HANWHA_DELTA.md` — Hanwha delta analysis
- ✅ `docs/run/STEP4L_REGRESSION_8INSURERS.md` — Regression test report
- ✅ `docs/run/STEP4L_SUMMARY.md` — This summary

---

## Next Steps (Optional)

### Short-term
1. Manual review of 17 remaining empty coverages
2. Precision validation of fallback evidence (human review)
3. Analyze if 4대특정암 variants can be decomposed further

### Long-term
1. Extend fallback to other insurers (if precision > 90%)
2. Add Fallback #3 for numeric pattern matching (e.g., "1회한" → "1회")
3. Add Fallback #4 for abbreviation expansion (e.g., "CAR-T" → "카르티")

---

## Conclusion

STEP 4-λ successfully achieved the DoD target (nonempty ≥ 18) with a deterministic, Hanwha-only enhancement. The implementation maintains:

- **Isolation**: Zero impact on 7 other insurers
- **Simplicity**: ~100 lines of code, no external dependencies
- **Traceability**: All fallback hits flagged in evidence pack
- **Quality**: 100% test pass rate

**Final Score**: 20/37 nonempty (54.1%) — up from 13/37 (35.1%)
**Improvement**: +7 coverages (+54% increase)

✅ **STEP 4-λ COMPLETE**

---

**Author**: Claude Code
**Date**: 2025-12-27
**Commit**: step4-λ
